Genentech, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 4625 NE Brookwood Pkwy, Hillsboro, Oregon (OR) 97124, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3007232634 · DUNS 833220176
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-04-19
- VAIDrug Quality Assurance2018-07-05
- VAIDrug Quality Assurance2016-04-15
- NAIDrug Quality Assurance2014-07-01
- VAIDrug Quality Assurance2012-06-27
- NAIDrug Quality Assurance2009-12-17
- NAIDrug Quality Assurance2008-11-14
Drugs this plant is listed as making
12 distinct drugs across 20 products name this site in their FDA label.
- Ado-Trastuzumab EmtansineGenentech, Inc.
- AlteplaseGenentech, Inc.
- atezolizumabGenentech, Inc.
- bevacizumabGenentech, Inc.
- omalizumabGenentech, Inc.
- PertuzumabGenentech, Inc.
- polatuzumab vedotinGenentech, Inc.
- RanibizumabGenentech, Inc.
- rituximabGenentech, Inc.
- tenecteplaseGenentech, Inc.
- tocilizumabGenentech, Inc.
- TrastuzumabGenentech, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.